Sort
40,608 grants matching “prostate cancer”
Project 2: Reversing resistance caused by lineage plasticity through epigenetic therapy
$433,322Yu Chen · Sloan-Kettering Inst Can Research · U54 · FY2017 · CA
Statistical Methods for Medical Tests and Biomarkers
$433,282Margaret S. Pepe · Fred Hutchinson Cancer Research Center · R01 · FY2009 · GM
Biomolecular Analysis using Liquid Crystals
$433,274Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2007 · CA
INHIBITION OF NEUROPILIN-2 TO ENHANCE IMMUNOTHERAPY OF LETHAL PROSTATE CANCER
$433,258University Of Massachusetts Medical School · · FY2021 · Defense Health Agency
VIRGINIA MASON COMMUNITY CLINICAL ONCOLOGY PROGRAM
$433,245Benaroya Research Inst At Virginia Mason · U10 · FY2003 · CA
Role of histotripsy synergized CD40 signaling in the re-engineering of cold tumors
$433,173Ashish Ranjan · Oklahoma State University Stillwater · R01 · FY2022 · CA
Lipid-Rich Macrophages at the Tumor-Adipose Interface: A New Target for Locally-Invasive Prostate Cancer Therapy
$433,157Simon W. Hayward · Endeavor Health Clinical Operations · R21 · FY2024 · CA
Shared Resource: Therapeutic Manufacturing
$433,092Ronald Manger · Fred Hutchinson Cancer Research Center · P30 · FY2015 · CA
Tele-based Psychosocial Intervention for Symptom Management & HRQOL in Men Living
$433,060Frank J Penedo · Northwestern University At Chicago · R01 · FY2016 · CA
Development of Protein Biomarkers in Post-DRE Urine for use in Liquid Biopsy of Prostate Cancer
$433,053Oliver John Semmes · Eastern Virginia Medical School · U01 · FY2020 · CA
The influence of selenium on biomarkers of prostate cancer risk
$433,034Karam E El-Bayoumy · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2011 · CA
Role of TbRIII in Regulating Motility and Invasion
$433,023Gerard C Blobe · Duke University · R01 · FY2009 · CA
Project 2 Fine-scale nucleosome repositioning of enhancers for hormone-independent genomic function
$433,019Qianben Wang · University Of Texas Hlth Science Center · U54 · FY2020 · CA
Parp Function in Prostate Cancer
$433,007Bryce M Paschal · University Of Virginia · R01 · FY2024 · CA
Genetic Epidemiology of Telomere Maintenance and Cancer Etiology
$432,958Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA
Optimizing Treatment Approaches to Lung Cancers Harboring MET Exon 14 mutations
$432,955Eric Collisson · University Of California, San Francisco · R01 · FY2019 · CA
Research Project
$432,954Swann Arp Adams · University Of South Carolina At Columbia · U54 · FY2014 · CA
Leveraging deep learning for markerless motion management in radiation therapy
$432,907Lei Xing · Stanford University · R01 · FY2025 · CA
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
$432,829Chendil Damodaran · Texas A&M University Health Science Ctr · R01 · FY2024 · CA
South-Eastern Center for Imaging Animal Models of Cancer
$432,762John C Gore · Vanderbilt University · U24 · FY2010 · CA
Novel Pathways in the Control of Lineage Plasticity in Neuroendocrine Prostate Cancer
$432,700Maria Teresa Diaz Meco Conde · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Improving prostate biopsy efficiency: The finasteride challenge test
$432,699Ian M Thompson · University Of Texas Hlth Science Center · R01 · FY2010 · CA
The Radium-223 Combination Therapy Space; Improving Response and Clarifying Toxicities
$432,694Daniel Lyndon Jaffe Thorek · Washington University · R01 · FY2021 · CA
The p62/MEKK3 complex in mTORC1 activation
$432,680Maria Teresa Diaz Meco Conde · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · CA
Regulation of tumor-infiltrating T cells by macrophages
$432,678Yiping Yang · Ohio State University · R01 · FY2023 · CA